Syndromic Testing Event
icon-infectious-disease-testing
Infectious disease

QIAGEN Virtual Event: Syndromic Testing for Infectious Diseases

Our approach to the diagnosis and management of infectious diseases has shifted dramatically in the wake of the COVID-19 pandemic. There has been an increased interest and need for multiplex PCR panel testing – widely known as syndromic testing – which can facilitate faster clinical decision making and infection control.

To explore how syndromic testing is currently being used in infectious disease diagnostics, we’re hosting a special virtual event on Wednesday, December 8, 2021. Join us as invited guests and internal experts discuss their experiences with syndromic testing and explore the past, present and future of this diagnostic tool.

This event is free to attend and has CPD accreditation.

Syndromic Testing for Infectious Diseases
Register today for the syndromic testing virtual event
icon-cta-blockquote2
Message from Davide Manissero, Chief Medical Officer, Medical and Scientific Affairs, QIAGEN:
“The last year and a half has been an exceptionally challenging and tumultuous time for microbiology laboratories and healthcare providers around the world, and COVID-19 has highlighted the need for more rapid and sensitive methods of molecular diagnostic testing. We hope this event will provide a forum for individuals in infectious diseases diagnostics to come together as we navigate an unprecedented respiratory season ahead.”
Wednesday, December 8, 2021
5:00 p.m. CET (8:00 a.m. PST) Welcome and introduction
Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN

5:05 p.m. CET

Multiplex PCR for the diagnostic evaluation of gastrointestinal infections
Prof Dr med Stephan Gehring, Department of Pediatrics, Children’s Hospital Universitätsmedizin Mainz, Germany

5:35 p.m. CET

Looking into the crystal ball: What will influenza-like illness season potentially look like
post-COVID-19 pandemic

Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, Department of Infectious Diseases, Infection Control,
and Employee Health, Division of Internal Medicine, MD Anderson Cancer Center, USA

6:05 p.m. CET

Respiratory syndromic testing for pediatrics – over-priced surveillance or thorough
diagnostic evaluation?

Susan A. Weaver, PhD, CLS, Clinical and Anatomic Laboratory Director, Natividad Medical Center, USA

6:35 p.m. CET

Panel discussion
Host: Davide Manissero MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN
Panelists:
  • Prof Dr med Stephan Gehring, Children’s Hospital Universitätsmedizin Mainz, Germany
  • Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA
  • Susan A. Weaver, PhD, CLS, Natividad Medical Center, USA

 

  • Davide Manissero, MD, MRCPCH, MSc, DTM&H
    Dr. Manissero is Chief Medical Officer – Infection and Immune Diagnostics at QIAGEN and Honorary Senior Lecturer in Public Health at the University College of London. His experience spans from diagnostic to drug development, and he has held senior public health positions at the WHO and European CDC.
    Davide Manissero, MD, MRCPCH, MSc, DTM&H
  • Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ
    Dr. Roy Chemaly is a tenured Professor of Medicine in the Department of Infectious Diseases, Infection Control & Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Chemaly completed his training in infectious diseases and medical microbiology at the Cleveland Clinic Foundation in Cleveland, Ohio. He is board-certified in internal medicine/infectious diseases, medical quality and medical microbiology.
    Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ
  • Prof Dr med Stephan Gehring
    Dr. Gehring is head of the Department of Pediatric Gastroenterology and Hepatology and is a senior consultant in the Pediatric Intensive Care Section at Johannes Gutenberg-Universität Mainz. He leads the scientific management of Pediatric Immunology and Infectiology. He is a specialist in pediatric and adolescent medicine.
    Stephan Gehring, Prof Dr Med
  • Susan A. Weaver, PhD, CLS
    Susan is the Clinical and Anatomic Laboratory Director at Natividad Hospital in Salinas, California, a Level II Trauma Center, that has received multiple awards for Maternity and Family Care. She works closely with the Monterey County Department of Public Health, as a consultant for Santa Cruz County Public Health and the University of California Santa Cruz COVID Laboratory.
    Susan A. Weaver, PhD, CLS
  • Davide Manissero, MD, MRCPCH, MSc, DTM&H
    Davide Manissero, MD, MRCPCH, MSc, DTM&H
  • Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ
    Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ
  • Stephan Gehring, Prof Dr Med
    Prof Dr med Stephan Gehring
  • Susan A. Weaver, PhD, CLS
    Susan A. Weaver, PhD, CLS
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm